European Journal of Heart Failure

Cover image for Vol. 19 Issue 7

Edited By: Prof. Marco Metra

Impact Factor: 6.968

ISI Journal Citation Reports © Ranking: 2016: 12/126 (Cardiac & Cardiovascular Systems)

Online ISSN: 1879-0844

Associated Title(s): ESC Heart Failure

OnlineOpen Articles


2017

The effects of short-term omission of daily medication on the pathophysiology of heart failure

The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective

Biomarkers
Variability of biomarkers in patients with chronic heart failure and healthy controls

Medical Therapy
Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction

Regenerative Therapy
An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial

Reviews
Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy

Myocardial fibrosis: biomedical research from bench to bedside

2016

Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people

Silent disease progression in clinically stable heart failure

A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry

Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial

Cardiac Regeneration
Clinical development plan for regenerative therapy in heart failure

Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design

Cardiac Remodelling
Significance of myocardial tenascin-C expression in left ventricular remodeling and long-term outcome in patients with dilated cardiomyopathy

Molecular and structural transition mechanisms in long-term volume overload

Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy

Comorbidities
Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study

Epidemiology and Screening
Global longitudinal strain: the best biomarker for predicting prognosis in heart failure?

Heart failure epidemiology 2000–2013: insights from the German Federal Health Monitoring System

Letters to the Editor
Response to: Hyperkalaemia in heart failure: binding the patient to improved treatment?

Medical Treatment
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial


2015

Clinical Trials
Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial

Reviews
Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?

Treatments
The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study

Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial

Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors

Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy

Diagnosis
MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure

Study Design
International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry

Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial

Increasing exercise capacity and quality of life of patients with heart failure through Wii gaming: the rationale, design and methodology of the HF-Wii study; a multicentre randomized controlled trial

Co-Morbidities
Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders

Prognosis
A simple validated method for predicting the risk of hospitalization for worsening of heart failure in ambulatory patients: the Redin-SCORE

Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy

Focus Issue on Cardiac Regeneration
Clinical development plan for regenerative therapy in heart failure

Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design

Focus Issue on Cardiac Regeneration
Response to: Hyperkalaemia in heart failure: binding the patient to improved treatment?


2014

Genetics
Ageing is a risk factor in imatinib mesylate cardiotoxicity

Pathophysiology
You have full Ca2+/calmodulin-dependent protein kinase II equally induces sarcoplasmic reticulum Ca2+ leak in human ischaemic and dilated cardiomyopathy

CRT
Implantable device diagnostics on day of discharge identify heart failure patients at increased risk for early readmission for heart failure

EAARN score, a predictive score for mortality in patients receiving cardiac resynchronization therapy based on pre-implantation risk factors

Clinical Trials
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome—an analysis from RELAX-AHF

Device Therapy
Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study

Symptoms
Symptoms of anxiety and depression and risk of heart failure: the HUNT Study

Biomarkers
Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device

Experiemental
Mitochondria selective S-nitrosation by mitochondria-targeted S-nitrosothiol protects against post-infarct heart failure in mouse hearts

Epidemiology
N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study

Study Design
Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF

Treatments
Baseline characteristics and treatment of patients in Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)


2013

Epidemiology
Reducing heart failure admission rates in England 2004–2011 are not related to changes in primary care quality: national observational study

Prognosis
Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure

Co-morbidity
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial

Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status

Study Design
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)

Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure

Clinical Trials
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

Diagnosis
High prevalence of undetected heart failure in long-term care residents: findings from the Heart Failure in Care Homes (HFinCH)

Experimental
Hyperpolarized 13C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart


2012

Diagnosis
Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure)

Experimental
Mechanical unloading reverses transverse tubule remodelling and normalizes local Ca2+-induced Ca2+release in a rodent model of heart failure

Pharmacoeconomics
Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK

Ranolazine for atrial fibrillation: buy one get three beneficial mechanisms!

Reviews
Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency

Treatment
Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial

SEARCH

SEARCH BY CITATION